klacid xl modified-release tablets 500mg
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - clarithromycin - modified-release tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid xl modified-release tablets 500mg
viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - modified-release tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid la 500mg modified release tablets
mylan ire healthcare limited - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms. indications include: lower respiratory tract infections for example bronchitis and pneumonia. upper respiratory tract infections for example sinusitis and pharyngitis. skin and soft tissue infections for example folliculitis, cellulitis and erysipelas.
klacid la 500mg modified release tablets
viatris healthcare limited - clarithromycin - modified-release tablet - macrolides; clarithromycin
klacid la 500 milligram modified-release tablets
abbott laboratories ireland ltd - clarithromycin - modified-release tablets - 500 milligram
klacid sr tablets modified-release film-coated
abbvie s.r.l. - clarithromycin - tablets modified-release film-coated - 500mg
klacid sr tablets modified-release film-coated
aesica queenborough limited - clarithromycin - tablets modified-release film-coated - 500mg (5/1x5/) in blister, (14/1x14/) in blister
klacid la modified-release 500mg tablets
pco manufacturing - clarithromycin - modified-release tablets - 500 milligram
klacid la 500 mg modified-release tablets
pco manufacturing ltd. - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin
klacid la 500 milligram modified-release tablets
b & s healthcare - clarithromycin - modified-release tablets - 500 milligram